Skip to main content
Equibles
DH logo

DH · Definitive Healthcare Corp.

Track DH — free

Use DH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.05 +0.01 (+0.96%) At close · Sep 4
Rebalance outlook locked
Market Cap
$112.08M
Shares
106.74M

DH metrics

74 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.05
Market cap
$112.08M

Price action

19 metrics
Price change (1W)
+30.9%
Price change (30D)
+47.1%
Price change (3M)
+17.1%
Price change (6M)
-11.0%
Price change (YTD)
-63.4%
Price change (1Y)
-73.8%
Trailing year
Price change (5Y)
—
52-week high
$4.30
52-week low
$0.63
Change from 52-week high
-75.6%
Change from 52-week low
+67.2%
Annualized volatility
76.7%
Beta
1.5
RSI (14D)
75.7
Price vs SMA 50
+37.7%
Price vs SMA 200
-23.9%
Avg volume (3M)
500,711
Relative volume
1.2
Average dollar volume
$422,469

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
106.74M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 261.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 207.6%
P / book
0.6
reciprocal yield 167.6%
FCF yield
25.5%
TTM · current market cap
Buyback yield
8.2%
P / FCF
3.9
reciprocal yield 25.5%
P / operating cash flow
2.7
reciprocal yield 37.0%
Earnings yield
-107.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.9×
reciprocal yield 52.8%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
8.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
75.2%
Operating margin
-104.6%
Trailing 12 months
Net margin
-51.7%
Gross profit (TTM)
$175.09M
Operating profit (TTM)
−$243.35M
Net income (TTM)
−$120.33M
Trailing 12 months
Diluted EPS (TTM)
$-1.65
FCF margin
12.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-9.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$232.70M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.7%
Revenue CAGR (5Y)
+15.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+10.8%
FCF CAGR (5Y)
+11.2%

Quality

14 metrics
Return on equity
-64.1%
Return on assets
-24.2%
Debt / equity
0.9
Current ratio
1.9
EBITDA (TTM)
−$239.44M
Free cash flow (TTM)
$28.56M
Quick ratio
1.9
Interest coverage
-21.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$22.96M
Latest balance sheet
Cash & equivalents
$170.87M
Total assets
$496.83M
Total debt
$160.63M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$41.43M
Capital expenditures (TTM)
$12.87M
R&D (TTM)
$30.76M
SG&A (TTM)
—
Stock compensation (TTM)
$25.32M
R&D / revenue
13.2%
Stock compensation / revenue
10.9%

Ownership (13F)

3 metrics
13F filers
100
13F filer change QoQ
-19
Institutional ownership
81.2%

Short interest

3 metrics
Short interest
1.9%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1861795 CUSIP 24477E103 13F (30d) 79 filings 78 filers Visit website Investor relations